» Articles » PMID: 9847344

Analysis of Murine CD8(+) T-cell Clones Specific for the Dengue Virus NS3 Protein: Flavivirus Cross-reactivity and Influence of Infecting Serotype

Overview
Journal J Virol
Date 1998 Dec 16
PMID 9847344
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Serotype-cross-reactive dengue virus-specific cytotoxic T lymphocytes (CTL) induced during a primary dengue virus infection are thought to play a role in the immunopathogenesis of dengue hemorrhagic fever (DHF) during a secondary dengue virus infection. Although there is no animal model of DHF, we previously reported that murine dengue virus-specific CTL responses are qualitatively similar to human dengue virus-specific CTL responses. We used BALB/c mice to study the specificity of the CTL response to an immunodominant epitope on the dengue virus NS3 protein. We mapped the minimal H-2Kd-restricted CTL epitope to residues 298 to 306 of the dengue type 2 virus NS3 protein. In short-term T-cell lines and clones, the predominant CD8(+) CTL to this epitope in mice immunized with dengue type 2 virus or vaccinia virus expressing the dengue type 4 virus NS3 protein were cross-reactive with dengue type 2 or type 4 virus, while broadly serotype-cross-reactive CTL were a minority population. In dengue type 3 virus-immunized mice, the predominant CTL response to this epitope was broadly serotype cross-reactive. All of the dengue virus-specific CTL clones studied also recognized the homologous NS3 sequences of one or more closely related flaviviruses, such as Kunjin virus. The critical contact residues for the CTL clones with different specificities were mapped with peptides having single amino acid substitutions. These data demonstrate that primary dengue virus infection induces a complex population of flavivirus-cross-reactive NS3-specific CTL clones in mice and suggest that CTL responses are influenced by the viral serotype. These findings suggest an additional mechanism by which the order of sequential flavivirus infections may influence disease manifestations.

Citing Articles

Protective Immunity to Dengue Virus Induced by DNA Vaccines Encoding Nonstructural Proteins in a Lethal Challenge Immunocompetent Mouse Model.

Alves R, Andreata-Santos R, de Freitas C, Pereira L, Fabris-Maeda D, Rodrigues-Jesus M Front Med Technol. 2022; 2:558984.

PMID: 35047876 PMC: 8757693. DOI: 10.3389/fmedt.2020.558984.


Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.

Saletti G, Gerlach T, Jansen J, Molle A, Elbahesh H, Ludlow M Sci Rep. 2020; 10(1):21447.

PMID: 33293664 PMC: 7722724. DOI: 10.1038/s41598-020-78506-9.


Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.

Shelly A, Gupta P, Ahuja R, Srichandan S, Meena J, Majumdar T Viruses. 2020; 12(10).

PMID: 33050511 PMC: 7599628. DOI: 10.3390/v12101150.


Cross-Reactive Immunity Among Flaviviruses.

Rathore A, St John A Front Immunol. 2020; 11:334.

PMID: 32174923 PMC: 7054434. DOI: 10.3389/fimmu.2020.00334.


Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.

Clemens E, van de Sandt C, Wong S, Wakim L, Valkenburg S Vaccines (Basel). 2018; 6(2).

PMID: 29587436 PMC: 6027237. DOI: 10.3390/vaccines6020018.


References
1.
Sumiyoshi H, Mori C, FUKE I, Morita K, Kuhara S, Kondou J . Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology. 1987; 161(2):497-510. DOI: 10.1016/0042-6822(87)90144-9. View

2.
Mackow E, Makino Y, Zhao B, Zhang Y, Markoff L, Buckler-White A . The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins. Virology. 1987; 159(2):217-28. DOI: 10.1016/0042-6822(87)90458-2. View

3.
Burke D, Nisalak A, Johnson D, Scott R . A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988; 38(1):172-80. DOI: 10.4269/ajtmh.1988.38.172. View

4.
Hoke C, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis B . Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med. 1988; 319(10):608-14. DOI: 10.1056/NEJM198809083191004. View

5.
Kurane I, Innis B, Nisalak A, Hoke C, Nimmannitya S, Meager A . Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest. 1989; 83(2):506-13. PMC: 303708. DOI: 10.1172/JCI113911. View